Podcast

Commercialization Readiness

Navigating Europe's complex commercialization landscape: essential steps for non-EU pharmaceutical companies

Pharmaceutical companies new to the EU market must navigate complex and varying commercialization requirements. The podcast highlights key steps for commercialization readiness in Europe, focusing on the challenges non-EU companies face, including supply chain logistics and regulatory complexities. Early planning, strategic partnerships, and understanding local regulations are essential for successful product launches in diverse European markets.

Subscribe to PharmaLex talks via one of the services below and get the newest episodes instantly.

Related resources

Cell and gene therapy commercialization

Article

Expert insights to help health systems navigate the challenges of CGT readiness

Webinar

Field services in focus: Supporting access in complex care pathways

Interview

Most Favored Nation (MFN): Implications for market access, launch strategy, and innovation